SENEB
Seneca Foods Corporation
SENEB's fundamentals are strong: revenue grew 12% and earnings per share about doubled, though free cash flow fell 36%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
SENEB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Healthy |
SENEB's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
SENEB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.4x | $76.18 | -56% |
| Current | 9.7x | $173 | — |
| Fair | 10x | $179 | +3.4% |
| Expensive | 15x | $260 | +50% |
Historical ranges are pointers, not guarantees.
SENEB's PE is 9.7x, but its earnings don't support one, so it isn't a reliable read right now.
SENEB Forward outlook
There aren't enough analyst estimates for SENEB to show an outlook.
SENEB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $17.28 | +100% |
| Q2 2026 | $17.30 | +177% |
| Q1 2026 | $16.59 | +181% |
| Q4 2025 | $13.01 | +132% |
| Q3 2025 | $8.63 | +45% |
| Q2 2025 | $6.24 | -15% |
| Q1 2025 | $5.90 | -31% |
| Q4 2022 | $6.18 | -6.5% |
SENEB earned $17.28 per share over the past year, up 100% from the year before.
SENEB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $492.6M | +7.1% |
| Q2 2026 | $405.2M | +36% |
| Q1 2026 | $393.8M | +14% |
| Q4 2025 | $508.3M | +1.1% |
| Q3 2025 | $460M | +8.1% |
| Q2 2025 | $297.5M | -2.4% |
| Q1 2025 | $345.8M | +12% |
| Q4 2024 | $502.9M | +13% |
SENEB's revenue has grown year over year for five quarters in a row: $493M last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.6% | -1.4 points |
| Q2 2026 | 6.5% | -1.3 points |
| Q1 2026 | 6% | +5.5 points |
| Q4 2025 | 12% | +6.7 points |
| Q3 2025 | 9% | +3.2 points |
| Q2 2025 | 7.8% | -0.5 points |
| Q1 2025 | 0.6% | -0.3 points |
| Q4 2024 | 5.1% | -1.8 points |
SENEB's operating margin was 7.6% last quarter, down 1.4 points from the same quarter a year ago.
SENEB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$45.5M | -309% |
| Q2 2026 | $91.9M | +117% |
| Q1 2026 | $93.1M | +14% |
| Q4 2025 | $22.9M | -79% |
| Q3 2025 | $21.8M | -69% |
| Q2 2025 | $42.4M | +11% |
| Q1 2025 | $81.4M | +102% |
| Q4 2024 | $108.7M | +$215.9M |
SENEB usually generates cash, though not every quarter: the latest was −$45M, but it generated $162M over the past year.
SENEB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -3K shares |
| 1 year | -1.3% | -88K shares |
| 3 years | -25% | -2.3M shares |
SENEB has 7M diluted shares, down 1.3% from a year ago, with $14M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.7M |
| Q2 2026 | $1.4M |
| Q1 2026 | $8.5M |
| Q4 2025 | $2.8M |
| Q3 2025 | $1.1M |
| Q2 2025 | $3.8M |
| Q1 2025 | $786,000 |
| Q4 2024 | $814,000 |
SENEB spent $14M buying back its own shares over the past year, up 121% from the year before.
SENEB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.9x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 2.3x | Moderate |
| Q1 2025 | 2.7x | Moderate |
| Q4 2024 | 3.5x | Elevated |
SENEB's net debt is less than a year of its operating earnings (EBITDA), down from 1.9 years a year ago.
SENEB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.5 | Neutral |
| Stochastic | 15.3 | Oversold |
SENEB's weekly RSI is 53 (neutral) and its Stochastic is 15 (oversold).
SENEB PE vs Consumer Defensive Sector
| Metric | SENEB | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 19x | 50% below |
| PE % | 42 | 17 | 25 pts above |
SENEB is trading at 9.7x earnings, a 50% discount to the Consumer Defensive sector's median of 19x, though its earnings don't support one.
SENEB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $169.3 | 2% above |
| 20 week MA | $176.5 | 2.1% below |
| 50 week MA | $151.6 | 14% above |
| 100 week MA | $123.9 | 40% above |
| 200 week MA | $89.3 | 94% above |
SENEB's trend is mixed: it's above four of its five weekly moving averages, and 94% above its 200-week average.
SENEB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.0 | $39.5 | -3.7% |
| 2021 | $39.5 | $46.6 | +18% |
| 2022 | $46.6 | $63.0 | +35% |
| 2023 | $63.0 | $51.7 | -18% |
| 2024 | $51.7 | $79.4 | +54% |
| 2025 | $79.4 | $114.5 | +44% |
| 2026 YTD | $114.5 | $172.8 | +51% |
SENEB has finished higher in four of the last six years. It's up 51% so far in 2026.